Novo CEO pressed by Senate to chop selling prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into account new talks with insurers with regard to the list costs of Wegovy and copyright if they pledge to keep the medicines on their https://kethek.com/